Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord

Internal Medicine Journal

Volumn 43, Issue 4, 2013, Pages 430-439

  Manochantr, S ^a   U pratya, Y ^b   Kheolamai, P ^a   Rojphisan, S ^a   Chayosumrit, M ^b   Tantrawatpan, C ^a   Supokawej, A ^c   Issaragrisil, S ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Amnion; Immunosuppressive; MSC; Placenta; Umbilical cord; Wharton's jelly

Indexed keywords

AMNION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE REACTION; NORMAL HUMAN; PLACENTA; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD; WHARTON JELLY;

AMNION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STROMAL CELLS; PLACENTA; PREGNANCY; T-LYMPHOCYTES; UMBILICAL CORD; WHARTON JELLY;

EID: 84875667664     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12044     Document Type: Article

References (36)

1. Thomas ED. Bone marrow transplantation: prospects for leukemia and other conditions. Proc Inst Med Chic 1975; 30: 256-258.
2. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P etal. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664-672.
3. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ etal. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
4. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19:180-192.
5. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S etal. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48.
6. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P etal. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
7. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD etal. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-4126.
8. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
9. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M etal. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
10. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-926.
11. De Girolamo L, Sartori MF, Arrigoni E, Rimondini L, Albisetti W, Weinstein RL etal. Human adipose-derived stem cells as future tools in tissue regeneration: osteogenic differentiation and cell-scaffold interaction. Int J Artif Organs 2008; 31: 467-479.
12. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W etal. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006; 91: 1017-1026.
13. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ etal. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330-1337.
14. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T etal. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008; 17: 1095-1107.
15. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant 2008; 17: 955-968.
16. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001; 82: 583-590.
17. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD etal. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995; 92: 4857-4861.
18. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M etal. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
19. Brooke G, Rossetti T, Pelekanos R, Ilic N, Murray P, Hancock S etal. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol 2009; 144: 571-579.
20. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26: 591-599.
21. Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang PH etal. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 2005; 15: 539-547.
22. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22: 649-658.
23. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J etal. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006; 30: 681-687.
24. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M etal. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007;7: 11.
25. Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang P etal. Isolation and identification of a multilineage potential mesenchymal cell from human placenta. Placenta 2005; 15: 539-547.
26. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D etal. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
27. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO etal. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25: 319-331.
28. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-1392.
29. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I etal. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586.
30. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H etal. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390-1397.
31. Muller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F etal. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Mol Dis 2008; 40: 25-32.
32. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-397.
33. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I etal. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008; 26: 2865-2874.
34. Fang B, Song YP, Liao LM, Han Q, Zhao RC. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006; 38: 389-390.
35. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J etal. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-3844.
36. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N etal. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 2007; 13:217-226.